VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
1.480
+0.040 (2.78%)
Apr 14, 2026, 9:44 AM EDT - Market open
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of $3.86 million as of April 14, 2026. Its market cap has decreased by -3.51% in one year.
Market Cap
3.86M
Enterprise Value
279.47K
1-Year Change
-3.51%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from $11.20M to $3.86M, a decrease of -65.54%. That is a compound annual growth rate of -7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.80M | -19.15% |
| Dec 31, 2025 | 4.70M | -33.80% |
| Dec 31, 2024 | 7.10M | -27.55% |
| Dec 29, 2023 | 9.80M | -20.33% |
| Dec 30, 2022 | 12.30M | -61.08% |
| Dec 31, 2021 | 31.60M | -61.84% |
| Dec 31, 2020 | 82.80M | 78.45% |
| Dec 31, 2019 | 46.40M | -58.16% |
| Dec 31, 2018 | 110.90M | -22.61% |
| Dec 29, 2017 | 143.30M | -59.30% |
| Dec 30, 2016 | 352.10M | 53.02% |
| Dec 31, 2015 | 230.10M | -60.58% |
| Dec 31, 2014 | 583.70M | -31.77% |
| Dec 31, 2013 | 855.50M | 600.66% |
| Dec 31, 2012 | 122.10M | 990.18% |
| Feb 14, 2012 | 11.20M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 4.38M |
| Revelation Biosciences | 4.35M |
| Akari Therapeutics, | 4.33M |
| Ensysce Biosciences | 4.31M |
| AIM ImmunoTech | 4.27M |
| Enveric Biosciences | 3.71M |
| Azitra | 3.68M |
| GRI Bio | 3.54M |